<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00815711</url>
  </required_header>
  <id_info>
    <org_study_id>2007H0002</org_study_id>
    <nct_id>NCT00815711</nct_id>
  </id_info>
  <brief_title>Idiopathic Pulmonary Fibrosis Registry for Future Studies</brief_title>
  <official_title>Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clay Marsh MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To establish a registry of patients for future studies of Inflammation in Interstitial Lung
      Disease/Idiopathic Pulmonary Fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To establish a framework in which biologic samples and physiologic measures from patients
      with IPF can be longitudinally collected and evaluated. Having a bank of samples that are
      correlated with physiologic measures that follow patients through their course will allow the
      following proposed studies as well as future investigations to be efficiently carried out.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Framework</measure>
    <time_frame>7 + years</time_frame>
    <description>To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated</description>
  </primary_outcome>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Lung Disease, Interstitial</condition>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood serum BAL fluid lung biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  any patient referred to the Interstitial Lund Disease clinic who is undergoing
             evaluation and or treatment for a new diagnosis of ILD. This can include patients
             referred for presumed pulmonary fibrosis/interstitial pneumonitis (IPF, UIP, NSIP),
             sarcoidosis, hypersensitivity pneumonitis, cryptogenic organising pneumonia,
             drug-induced, or other idiopathic ILDs.

        Exclusion Criteria:

          -  pregnancy

          -  inability to follow study requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clay B Marsh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Janice E Drake, CRTT</last_name>
    <phone>614-688-2287</phone>
    <email>janice.drake@osumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sharon T Cheung, BS</last_name>
    <phone>614-366-2258</phone>
    <email>sharon.cheung@osumc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice E Drake, CRTT</last_name>
    </contact>
    <investigator>
      <last_name>James N Allen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nitin Y Bhatt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Baran, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2008</study_first_submitted>
  <study_first_submitted_qc>December 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2008</study_first_posted>
  <last_update_submitted>August 21, 2014</last_update_submitted>
  <last_update_submitted_qc>August 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Clay Marsh MD</investigator_full_name>
    <investigator_title>SR Assoc VP for Health Sciences Research, Vice Dean of Research for the College of Medicine, Executive Director of the Center for Personalized Health Care, Director of the Center for Critical and Respiratory Care</investigator_title>
  </responsible_party>
  <keyword>IPF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

